The vision of the Company is to make a meaningful difference in cancer treatment through its innovative novel diagnostic tests, which give the physician the ability for superior treatment of cancer. The Company aims to launch a series of in-vitro diagnostic tests for improved management of cancer through personalization of treatment and undertake early development of novel cancer drugs.
  • To launch a series of first-in-class novel proprietary in-vitro diagnostic tests invented by the Company’s Scientific Founders, initially in India followed by the rest of the world.
  • To develop new devices to accompany the Company’s proprietary diagnostic tests that are user-friendly, cheaper, more efficient, and in some cases can be used in a point-of-care setting
  • To develop novel first-in-class drug candidates invented by the Company’s Scientific Founders, which addresses a true medical need in controlling metastasis, the primary cause of cancer-mediated mortality.